|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 108, Issue 8 2811-2823, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
M Dundr, GH Leno, ML Hammarskjold, D Rekosh, C Helga-Maria and MO Olson
Department of Biochemistry, University of Mississippi Medical Center, Jackson 39216, USA.
The human immunodeficiency virus 1 (HIV-1) Rev transactivator protein plays a critical role in the regulation of expression of structural proteins by controlling the pathway of mRNA transport. The Rev protein is located predominantly in the nucleoli of HIV-1 infected or Rev-expressing cells. Previous studies demonstrated that the Rev protein forms a specific complex in vitro with protein B23 which is suggested to be a nucleolar receptor and/or carrier for the Rev protein. To study the role of the nucleolus and nucleolar proteins in Rev function, transfected COS-7 or transformed CMT3 cells expressing the Rev protein were examined for subcellular locations of Rev and other proteins using indirect immunofluorescence and immunoelectron microscopy. One day after transfection the Rev protein was found in most cells only in the nucleolar dense fibrillar and granular components where it colocalized with protein B23. These were designated class 1 cells. In a second class of cells Rev and B23 accumulated in the nucleoplasm as well as in nucleoli. Treatment of class 1 cells with actinomycin D (AMD) under conditions that blocked only RNA polymerase I transcription caused Rev to completely redistribute from nucleoli to the cytoplasm. Simultaneously, protein B23 was partially released from nucleoli, mostly into the nucleoplasm, with detectable amounts in the cytoplasm. In cells recovering from AMD treatment in the presence of cycloheximide Rev and B23 showed coincident relocation to nucleoli. Class 2 cells were resistant to AMD-induced Rev redistribution. Selective inhibition of RNA polymerase II transcription by alpha-amanitin or by DRB did not cause Rev to be released into the cytoplasm suggesting that active preribosomal RNA transcription is required for the nucleolar location of Rev. However, treatment with either of the latter two drugs at higher doses and for longer times caused partial disruption of nucleoli accompanied by translocation of the Rev protein to the cytoplasm. These results suggest that the nucleolar location of Rev depends on continuous preribosomal RNA transcription and a substantially intact nucleolar structure.
This article has been cited by other articles:
|
|
 |
|
  J. Fellay, K. V. Shianna, D. Ge, S. Colombo, B. Ledergerber, M. Weale, K. Zhang, C. Gumbs, A. Castagna, A. Cossarizza, et al. A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 Science, August 17, 2007; 317(5840): 944 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Grieger, S. Snowdy, and R. J. Samulski Separate Basic Region Motifs within the Adeno-Associated Virus Capsid Proteins Are Essential for Infectivity and Assembly. J. Virol., June 1, 2006; 80(11): 5199 - 5210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Huang, S. Negi, A. Szebeni, and M. O. J. Olson Protein NPM3 Interacts with the Multifunctional Nucleolar Protein B23/Nucleophosmin and Inhibits Ribosome Biogenesis J. Biol. Chem., February 18, 2005; 280(7): 5496 - 5502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ning and C. Shih Nucleolar Localization of Human Hepatitis B Virus Capsid Protein J. Virol., December 15, 2004; 78(24): 13653 - 13668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Germi, P. Morand, K. Brengel-Pesce, S. Fafi-Kremer, O. Genoulaz, C. Ginevra, M. Ballout, G. Bargues, and J.-M. Seigneurin Quantification of gp350/220 Epstein-Barr Virus (EBV) mRNA by Real-Time Reverse Transcription-PCR in EBV-Associated Diseases Clin. Chem., October 1, 2004; 50(10): 1814 - 1817. [Full Text] [PDF]
|
|
|
|
 |
|
 A. MICHIENZI, D. CASTANOTTO, N. LEE, S. LI, J. A. ZAIA, and J. J. ROSSI RNA-Mediated Inhibition of HIV in a Gene Therapy Setting Ann. N.Y. Acad. Sci., December 1, 2003; 1002(1): 63 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Michienzi, S. Li, J. A. Zaia, and J. J. Rossi A nucleolar TAR decoy inhibitor of HIV-1 replication PNAS, October 29, 2002; 99(22): 14047 - 14052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Cmarko, S.-O. Boe, C. Scassellati, A. M. Szilvay, S. Davanger, X.-D. Fu, G. Haukenes, K.-H. Kalland, and S. Fakan Rev Inhibition Strongly Affects Intracellular Distribution of Human Immunodeficiency Virus Type 1 RNAs J. Virol., September 11, 2002; 76(20): 10473 - 10484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chen, T. Wurm, P. Britton, G. Brooks, and J. A. Hiscox Interaction of the Coronavirus Nucleoprotein with Nucleolar Antigens and the Host Cell J. Virol., April 16, 2002; 76(10): 5233 - 5250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wurm, H. Chen, T. Hodgson, P. Britton, G. Brooks, and J. A. Hiscox Localization to the Nucleolus Is a Common Feature of Coronavirus Nucleoproteins, and the Protein May Disrupt Host Cell Division J. Virol., October 1, 2001; 75(19): 9345 - 9356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Matthews Adenovirus Protein V Induces Redistribution of Nucleolin and B23 from Nucleolus to Cytoplasm J. Virol., January 15, 2001; 75(2): 1031 - 1038. [Abstract] [Full Text]
|
|
|
|
|
|
D. M. D'Agostino, T. Ferro, L. Zotti, F. Meggio, L. A. Pinna, L. Chieco-Bianchi, and V. Ciminale Identification of a Domain in Human Immunodeficiency Virus Type 1 Rev That Is Required for Functional Activity and Modulates Association with Subnuclear Compartments Containing Splicing Factor SC35 J. Virol., December 15, 2000; 74(24): 11899 - 11910. [Abstract] [Full Text]
|
|
|
|
|
|
A. Michienzi, L. Cagnon, I. Bahner, and J. J. Rossi Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA PNAS, August 1, 2000; 97(16): 8955 - 8960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Clau{beta}en, F. Rudt, and T. Pieler Functional Modules in Ribosomal Protein L5 for Ribonucleoprotein Complex Formation and Nucleocytoplasmic Transport J. Biol. Chem., November 26, 1999; 274(48): 33951 - 33958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ludwig, F. C. Silberstein, J. van Empel, V. Erfle, M. Neumann, and R. Brack-Werner Diminished Rev-Mediated Stimulation of Human Immunodeficiency Virus Type 1 Protein Synthesis Is a Hallmark of Human Astrocytes J. Virol., October 1, 1999; 73(10): 8279 - 8289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Melnick and J. D. Licht Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia Blood, May 15, 1999; 93(10): 3167 - 3215. [Full Text] [PDF]
|
|
|
|
|
|
C. Helga-Maria, M.-L. Hammarskjöld, and D. Rekosh An Intact TAR Element and Cytoplasmic Localization Are Necessary for Efficient Packaging of Human Immunodeficiency Virus Type 1 Genomic RNA J. Virol., May 1, 1999; 73(5): 4127 - 4135. [Abstract] [Full Text]
|
|
|
|
|
|
S. L. Thomas, M. Oft, H. Jaksche, G. Casari, P. Heger, M. Dobrovnik, D. Bevec, and J. Hauber Functional Analysis of the Human Immunodeficiency Virus Type 1 Rev Protein Oligomerization Interface J. Virol., April 1, 1998; 72(4): 2935 - 2944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Zirwes, M. S. Schmidt-Zachmann, and W. W. Franke Identification of a small, very acidic constitutive nucleolar protein (NO29) as a member of the nucleoplasmin family PNAS, October 14, 1997; 94(21): 11387 - 11392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Aarts, D. Davidson, A. Corluka, E. Petroulakis, J. Guo, F. R. Bringhurst, J. Galipeau, and J. E. Henderson Parathyroid Hormone-related Protein Promotes Quiescence and Survival of Serum-deprived Chondrocytes by Inhibiting rRNA Synthesis J. Biol. Chem., October 5, 2001; 276(41): 37934 - 37943. [Abstract] [Full Text] [PDF]
|
|
